Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaceutical Technology ↗
Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.…
The WeekPharmaceutical Technology ↗
The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and d…
The WeekSTAT News ↗
A CMS rule finalized this week may prove more difficult to challenge than previous Trump administration action…
The WeekBioPharma Dive ↗
The findings position their drug, zipalertinib, as a threat to multiple approved medicines - while setting a b…
The WeekPharmaVoice ↗
New government funding from Pennsylvania to Kansas City is strengthening biotech hubs - but experts say money …
The WeekFiercePharma ↗
Abbott is again tapping into the competitive spirit of Big Ten universities to drive blood donations, pitting …
The WeekFierceBiotech ↗
Taiho Pharmaceutical and Cullinan Therapeutics have celebrated a second phase 3 victory for their small-molecu…
The WeekBriefing
FDA on August 12, 2026 announced a final guidance on formal meetings between the agency and sponsors or applic…
The WeekSTAT News ↗
When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is t…
The WeekPharmaceutical Technology ↗
Remepy has secured $36m in Series A funds to accelerate its pharmaceutical co-development partnerships and exp…
The WeekBioPharma Dive ↗
Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of…
The WeekPharmaVoice ↗
Dr. Michael Ehlers bets AI can ease the clinical-development bottleneck - but scaling Formation Bio's pipeline…
The WeekFiercePharma ↗
Snapchat is courting pharma marketers with a new ad format designed to support the disclosure needs of branded…
The WeekFierceBiotech ↗
Boulevard Bio has strolled out of stealth with $65 million in funding from Deerfield Management and three auto…
The WeekBriefing
Takeda secured FDA approval for oveporexton, branded Orzeyful, for adults with narcolepsy type 1. The approval…
The WeekSTAT News ↗
German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now h…
The WeekBioPharma Dive ↗
Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects from China-based biotechs and…
The WeekPharmaVoice ↗
Why treatments from Alnylam, Merck, AbbVie and Roche stumbled in the last quarter.…
The WeekPharmaVoice ↗
The executive order - which wasn't accompanied by any new scientific evidence - aims to split the MMR vaccine …
The WeekFiercePharma ↗
President Donald Trump signed an executive order Monday that calls for reducing the number of required vaccina…
The WeekFierceBiotech ↗
The FDA has denied ITM Isotopes Technologies' lead pipeline candidate for a rare group of tumors due to qualms…
The WeekBriefing
Tenax is still trying to bring levosimendan to the U.S., but the latest phase 3 stumble underscores how little…
The WeekDrug Channels ↗
By Bryce Platt, PharmD The United States has almost 8,000 fewer retail pharmacies than it did in 2018, and mor…
The WeekSTAT News ↗
Biotech companies don't hide or obfuscate strong data.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.